Hyalubrix 60 mg/4 ml 1 syringe joint infiltration

Hyalubrix 60 mg/4 ml 1 syringe pieces joint infiltration is a sterile viscoelastic solution based on hyaluronic acid sodium salt, obtained through bacterial fermentation and characterized by a high molecular weight . This product is designed for joint infiltration and comes in practical 4 ml pre-filled syringes , ideal for safe and precise use. Hyaluronic acid is a natural component of synovial fluid and cartilage, essential for ensuring the viscosity and elasticity necessary to protect joints from mechanical damage and to promote lubrication and cushioning.

Hyalubrix 60 mg is indicated for the treatment of joint pain and improvement of joint function in patients with degenerative or mechanical arthropathy of the knee, hip, shoulder, ankle, and trapeziometacarpal joint. Intra-articular injection of Hyalubrix helps restore the viscoelastic properties of synovial fluid , reducing pain and improving joint mobility for up to six months. It is particularly indicated in cases where analgesics and nonsteroidal anti-inflammatory drugs have failed or are poorly tolerated.

The high-purity formulation of Hyalubrix 60 mg ensures excellent tolerability and safety. Each pack contains one 4 ml pre-filled syringe , each containing 60 mg of hyaluronic acid, ready for use in targeted intra-articular injections . Choose Hyalubrix for effective treatment of osteoarthritis and joint diseases, with the guarantee of a superior quality product, designed for the well-being of your joints .

Dosage and method of use

How do I use Hyalubrix 60 mg/4 ml joint infiltration syringe?

The injection must be strictly intra-articular. Intra-articular injections must be performed according to standard technique, using a precise anatomical location. In the hip, ultrasound or radioscopic guidance is recommended.
If there is a spill, remove it before administering the product.
All rules regarding asepsis and injection techniques must be observed.
Inject HYALUBRIX 60 using a suitable sterile needle (e.g. 18 or 20 G), into the affected joint.
After the first application, further treatments may be necessary to maintain the benefits of the treatment over time, depending on the needs of the individual patient.
Clinical data show that the efficacy of HYALUBRIX 60 persists for up to 6 months. A further injection, if clinically required, should be administered after this time period.

Average analysis Hyalubrix 60 mg/4 ml syringe joint infiltration

What does Hyalubrix 60 mg/4 ml syringes 1 syringe joint infiltration contain?

Hyaluronic acid sodium salt 1.5%, sodium chloride, disodium hydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, water for injections.

Ingredients Hyalubrix 60 mg/4 ml syringe joint infiltration

What ingredients does Hyalubrix 60 mg/4 ml 1 syringe joint infiltration contain?

Hyaluronic acid sodium salt 1.5%, sodium chloride, disodium hydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, water for injections.

Warnings

What are the warnings for Hyalubrix 60 mg/4 ml joint infiltration syringe?

Do not administer to patients with known individual sensitivity to the product components. Do not administer in case of infections or skin diseases in the injection area. Do not administer to patients with active synovitis. The safety and efficacy of HYALUBRIX in pregnant women, breastfeeding women, or individuals under 18 years of age have not been established and therefore its use is contraindicated in these patient populations. Do not use if the package is damaged. Do not use the product after the expiry date shown on the package. The expiry date refers to the product stored in its original packaging. The syringe is for single use only, meaning it is for single use only and on a single patient. Inject the contents into one joint only. For the first 24 hours after the injection, the patient is permitted to continue all routine daily activities, but it is recommended not to overload the treated joint. The syringe complete with needle must be discarded immediately after use, even if the solution has not been completely administered. If the product is reprocessed and/or reused, Fidia Farmaceutici cannot guarantee its performance, functionality, material structure, cleanliness, or sterility. Reuse may lead to illness, infection, and/or harm to the patient or user. Dispose of it according to applicable regulations after use. Keep out of reach of children.
Localized pain, swelling, heat, and redness may occasionally occur at the injection site. These symptoms are generally mild and transient. After intra-articular injection, applying an ice pack to the treated joint for five to ten minutes will reduce the incidence of these events. Local or systemic allergic reactions may occur in individuals with hypersensitivity to the product's components. More marked inflammatory reactions, sometimes with the presence of sodium pyrophosphate crystals, have occasionally been reported in association with intra-articular injections of hyaluronate. As with any intra-articular treatment, septic arthritis may rarely occur if general injection precautions are not observed or the injection site is not aseptic.
Do not use concomitantly with disinfectants containing quaternary ammonium salts, as hyaluronic acid may precipitate in their presence. Avoid concomitant administration of HYALUBRIX with other products for intra-articular use to prevent any possible interactions.

Hyalubrix 60 mg/4 ml syringe format for joint infiltration

1 pre-filled syringe with 60 mg of hyaluronic acid in 4 ml of solution.